Human Genome Epidemiology Literature Finder
Records 1 - 20 (of 20 Records) |
Query Trace: Ovarian Neoplasms and ERBB2[original query] |
---|
655Val and 1170Pro ERBB2 SNPs in familial breast cancer risk and BRCA1 alterations. Cellular oncology : the official journal of the International Society for Cellular Oncology 2007 29 (3): 241-8. Tommasi Stefania, Fedele Vita, Lacalamita Rosanna, Bruno Michele, Schittulli Francesco, Ginzinger David, Scott Gery, Eppenberger-Castori Serenella, Calistri Daniele, Casadei Silvia, Seymour Ian, Longo Salvatore, Giannelli Gianluigi, Pilato Brunella, Simone Giovanni, Benz Christopher C, Paradiso Ange |
The effects of common genetic variants in oncogenes on ovarian cancer survival. Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Sep 14 (18): 5833-9. Quaye Lydia, Gayther Simon A, Ramus Susan J, Di Cioccio Richard A, McGuire Valerie, Hogdall Estrid, Hogdall Claus, Blaakr Jan, Easton Douglas F, Ponder Bruce A J, Jacobs Ian, Kjaer Susanne Kruger, Whittemore Alice S, Pearce Celeste Leigh, Pharoah Paul D P, Song Hongl |
Molecular genetics analysis of hereditary breast and ovarian cancer patients in India. Hereditary cancer in clinical practice 2009 7 (1): 13. Soumittra Nagasamy, Meenakumari Balaiah, Parija Tithi, Sridevi Veluswami, Nancy Karunakaran N, Swaminathan Rajaraman, Rajalekshmy Kamalalayam R, Majhi Urmila, Rajkumar Thangaraj |
Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas. Cancer research 2009 May 69 (9): 4036-42. Kuo Kuan-Ting, Guan Bin, Feng Yuanjian, Mao Tsui-Lien, Chen Xu, Jinawath Natini, Wang Yue, Kurman Robert J, Shih Ie-Ming, Wang Tian- |
Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer. British journal of cancer 2009 Mar 100 (6): 993-1001. Quaye L, Song H, Ramus S J, Gentry-Maharaj A, Høgdall E, DiCioccio R A, McGuire V, Wu A H, Van Den Berg D J, Pike M C, Wozniak E, Doherty J A, Rossing M A, Ness R B, Moysich K B, Høgdall C, Blaakaer J, , Easton D F, Ponder B A J, Jacobs I J, Menon U, Whittemore A S, Krüger-Kjaer S, Pearce C L, Pharoah P D P, Gayther S |
Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms. BMC cancer 2015 15 (1): 415. Mackenzie Robertson, Kommoss Stefan, Winterhoff Boris J, Kipp Benjamin R, Garcia Joaquin J, Voss Jesse, Halling Kevin, Karnezis Anthony, Senz Janine, Yang Winnie, Prigge Elena-Sophie, Reuschenbach Miriam, Doeberitz Magnus Von Knebel, Gilks Blake C, Huntsman David G, Bakkum-Gamez Jamie, McAlpine Jessica N, Anglesio Michael |
Profiling of actionable gene alterations in ovarian cancer by targeted deep sequencing. International journal of oncology 2015 Jun 46 (6): 2389-98. Takenaka Masataka, Saito Motonobu, Iwakawa Reika, Yanaihara Nozomu, Saito Misato, Kato Mamoru, Ichikawa Hitoshi, Shibata Tatsuhiro, Yokota Jun, Okamoto Aikou, Kohno Takas |
A SNaPshot of potentially personalized care: Molecular diagnostics in gynecologic cancer. Gynecologic oncology 2016 Apr 141 (1): 108-12. Penson R T, Sales E, Sullivan L, Borger D R, Krasner C N, Goodman A K, Del Carmen M G, Growdon W B, Schorge J O, Boruta D M, Castro C M, Dizon D S, Birrer M |
Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer. Journal of molecular medicine (Berlin, Germany) 2016 Feb . Er Tze-Kiong, Su Yu-Fa, Wu Chun-Chieh, Chen Chih-Chieh, Wang Jing, Hsieh Tsung-Hua, Herreros-Villanueva Marta, Chen Wan-Tzu, Chen Yi-Ting, Liu Ta-Chih, Chen Hung-Sheng, Tsai Eing-M |
Identification of somatic genetic alterations in ovarian clear cell carcinoma with next generation sequencing. Genes, chromosomes & cancer 2018 02 57 (2): 51-60. Shibuya Yusuke, Tokunaga Hideki, Saito Sakae, Shimokawa Kazurou, Katsuoka Fumiki, Bin Li, Kojima Kaname, Nagasaki Masao, Yamamoto Masayuki, Yaegashi Nobuo, Yasuda J |
Loss of 1p36.33 Frequent in Low-Grade Serous Ovarian Cancer. Neoplasia (New York, N.Y.) 2019 May 21 (6): 582-590. Van Nieuwenhuysen Els, Busschaert Pieter, Laenen Annouschka, Moerman Philippe, Han Sileny N, Neven Patrick, Lambrechts Diether, Vergote Igna |
Landscape of BRIP1 molecular lesions in gastrointestinal cancers from published genomic studies. World journal of gastroenterology 2020 4 26 (11): 1197-1207. Voutsadakis Ioannis |
Association of Germline Variant Status With Therapy Response in High-risk Early-Stage Breast Cancer: A Secondary Analysis of the GeparOcto Randomized Clinical Trial. JAMA oncology 2020 3 6 (5): 744-748. Pohl-Rescigno Esther, Hauke Jan, Loibl Sibylle, Möbus Volker, Denkert Carsten, Fasching Peter A, Kayali Mohamad, Ernst Corinna, Weber-Lassalle Nana, Hanusch Claus, Tesch Hans, Müller Volkmar, Altmüller Janine, Thiele Holger, Untch Michael, Lübbe Kristina, Nürnberg Peter, Rhiem Kerstin, Furlanetto Jenny, Lederer Bianca, Jackisch Christian, Nekljudova Valentina, Schmutzler Rita K, Schneeweiss Andreas, Hahnen Er |
Prevalence of pathogenic variants in actionable genes in advanced ovarian cancer: a next-generation sequencing analysis of a nationwide registry study. European journal of cancer (Oxford, England : 1990) 2020 11 141 185-192. Kang Sokbom, Yu Ye L, Cho Soo Y, Park Seog-Y |
Therapeutic options for mucinous ovarian carcinoma. Gynecologic oncology 2020 Jan . Gorringe Kylie L, Cheasley Dane, Wakefield Matthew J, Ryland Georgina L, Allan Prue E, Alsop Kathryn, Amarasinghe Kaushalya C, Ananda Sumitra, Bowtell David D L, Christie Michael, Chiew Yoke-Eng, Churchman Michael, DeFazio Anna, Fereday Sian, Gilks C Blake, Gourley Charlie, Hadley Alison M, Hendley Joy, Hunter Sally M, Kaufmann Scott H, Kennedy Catherine J, Köbel Martin, Le Page Cecile, Li Jason, Lupat Richard, McNally Orla M, McAlpine Jessica N, Pyman Jan, Rowley Simone M, Salazar Carolina, Saunders Hugo, Semple Timothy, Stephens Andrew N, Thio Niko, Torres Michelle C, Traficante Nadia, Zethoven Magnus, Antill Yoland C, Campbell Ian G, Scott Clare |
Genetic alterations and their therapeutic implications in epithelial ovarian cancer. BMC cancer 2021 5 21 (1): 499. Lapke Nina, Chen Chien-Hung, Chang Ting-Chang, Chao Angel, Lu Yen-Jung, Lai Chyong-Huey, Tan Kien Thiam, Chen Hua-Chien, Lu Hsiao-Yun, Chen Shu-J |
Correlation between SNPs of PIK3CA, ERBB2 3'UTR, and their interactions with environmental factors and the risk of epithelial ovarian cancer. Journal of assisted reproduction and genetics 2021 Apr . Chen Haibo, Zhai Zhenyuan, Xie Qinghai, Lai Yuanbin, Chen Guipi |
Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directions. Gynecologic oncology 2023 11 180 1-5. Dimitrios Nasioudis, Stefan Gysler, Nawar Latif, Lory Cory, Robert L Giuntoli, Sarah H Kim, Fiona Simpkins, Lainie Martin, Emily M |
Investigation of the prevalence and clinical implications of ERBB2 exon 16 skipping mutations in Chinese pan-cancer patients. Frontiers in oncology 2023 1 12 1064598. Shang Yanhong, Mo Jianming, Huo Ran, Li Xiaofang, Fang Guotao, Wei Zichun, Gu Guomin, Zhu Xiaodan, Zhang Chan, Liu Chunling, Yan Do |
Genomic Landscape of Endometrial, Ovarian, and Cervical Cancers in Japan from the Database in the Center for Cancer Genomics and Advanced Therapeutics. Cancers 2024 1 16 (1): . Qian Xi, Hidenori Kage, Miho Ogawa, Asami Matsunaga, Akira Nishijima, Kenbun Sone, Kei Kawana, Katsutoshi O |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: